0% found this document useful (0 votes)
23 views76 pages

Fatty Acid Oxidation and Mobilization

Uploaded by

yosefkebeba7
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
23 views76 pages

Fatty Acid Oxidation and Mobilization

Uploaded by

yosefkebeba7
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Oxidation of fatty acid

1
Cont.…
Mobilization of stored fats

• Fatty acids stored in adipose tissue (TAG) coated with


perilipins serve as the body’s major fuel storage reserve

• The mobilization of stored fat requires the hydrolytic


release of fatty acids and glycerol from TAG

• Hormone sensitive lipase (HSL) removes FA from C1

2
Mobilization of triacylglycerols stored in adipose tissue 4
Cont.…
• Hormones that activate HSL
• Catecholamine's
• Glucagon
• Growth hormone
• Glucocorticoids

• Binding hormones to receptors on adipocytes membrane, activate


Adenyl cyclase to produces cAMP which activate Protein kinase (PK)

• A cascade mechanism release FA & glycerol from TAG molecule

5
Cont.…

Regulation of lipolysis
• Insulin decreases lipolysis, but increase esterification of fatty
acids
• By :
❖ Inhibiting adenyl cyclase →→ decreases levels of cAMP

❖ Enhances the uptake of glucose into adipose cells

o α-Glycerol-3-P

6
Cont.…
• When lipolysis is turned on, FA synthesis is turned off

• B/c acetyl CoA carboxylase is inhibited by hormone


directed phosphorylation

• cAMP-mediated cascade is activated as in starvation or


diabetes

• High plasma levels of insulin and glucose in a well fed


state:

• HSL is dephosphorylated (inactive), so lipolysis is turned


off,and fatty acid synthesis and lipogenesis is turned on 7
Summary

8
Cont.…
Fates of glycerol
• Glycerol cannot be utilized by adipocyte due to lacks of
glycerol kinase

• Glycerol is used by the liver to produce glycerol-3-phosphate


❖ glycolysis
❖ gluconeogenesis
❖ synthesis of TAGs
Fates of FFAs
• FFAs are transported in blood in association with serum
albumin-FFAs complex
• Most cells can oxidize FAs to obtain energy (ATP)
• Exception: Brain, Nervous tissues, RBC & Adrenal medulla 9
β-Oxidation of fatty acids
• FFAs are oxidized in tissue to produce energy
• Types
❖ α- oxidation
❖ β- oxidation
❖ ω- oxidation
• β- oxidation is the major method by which FA is oxidized
• There are 3 stages:
❖ Activation
❖ Transport
❖ Degradation
10
Cont.…

[Link]
• Fatty acid is activated to fatty acyl CoA by fatty
acyl CoA synthetase (thiokinase) in the cytosol fatty acyl–CoA
synthetase

AMP + PPi
Phosphatase

11
Cont.…

[Link] into the mitochondria


• Fatty acyl CoA must be transported across the
inner mitochondrial membrane

• Carnitine transports the acyl group from the


cytosol into the mitochondrial matrix

• Carnitine shuttle

• A rate-limiting transport process

12
Role of carnitine in transport of acyl groups
CAT = Carnitine acyl transferase 13
Cont.…
Regulation of CAT I
• CAT-I is related to the outer mitochondrial membrane

• CAT-I reaction is rate limiting

• The enzyme is allosterically inhibited by malonyl CoA

• Malonyl CoA concentration could be high during fatty


acid synthesis

• Inhibition of CAT-I by Malonyl CoA prevents


simultaneous synthesis & degradation of fatty acids
14
Cont.…
Sources of Carnitine

• Diet: meat

• Synthesis in liver & kidney from lysine & methionine

• Skeletal muscle : 97%

• Skeletal & cardiac muscles are entirely depend on


carnitine produced by hepatocytes or taken in diet

15
Cont.…
Deficiency of Carnitine
• Primary cause
❖CAT-II : mainly affects skeletal & cardiac muscle
: inability to use LCFAs

❖CAT-I : affects the liver


: liver can not uses LCFAS to synthesize
glucose during fasting
: fasting hypoglycemia

• Secondary : liver disease, malnutrition, physiologica


change, hemodialysis

• Rx??? 16
Cont.…
3. β- oxidation
• “Mitochondrial pathway, in which 2 carbon fragments are successively
removed from the carboxyl end of the fatty acyl CoA”

• Products
❖ FADH2
❖ NADH
❖ Acetyl CoA

17
Cont.…
• There are four individual reactions each
catalyzed by a separate enzyme

• First Oxidation

• Dehydrogenation between carbon 2 & 3 in


a FAD-linked reaction

• Acyl CoA dehydrogenase

• Produce
❖ trans-∆2-Enol CoA
❖ FADH2 18
Cont.…
• Hydration
• Hydration of the double
bond

• Enoyl CoA Hydratase

• L-3-Hydroxyacyl CoA

19
Cont.…

• Second Oxidation

• Dehydrogenation in a NAD-linked
reaction

• 3-hydroxyacyl Co A dehydrogenase

20
Cont.…
• Cleavage

• Thiolytic cleavage of the thioester

• Beta-ketoacyl CoA thiolase

• Shortened acyl CoA by 2 carbon


atoms

• Acetyl CoA

NB: This 4 steps are repeated until the fatty Acyl chain is completely degraded to Acetyl CoA or
propionyl Co A
21
22
Cont.…
Energy produced from palmitic acid (C-16)
• Each round of degradation produces, one
FADH2, one NADH and one acetyl CoA molecule

8 Acetyl CoA →→ 96 ATP


7 FADH2 →→ 14 ATP
7 NADH →→ 21 ATP
= 131 ATPs
• 2 ATPs utilized to activate fatty acid

• Net gain 131–2


= 129 ATPs
What is the total ATP yield in odd number fatty acid oxidation
23
such as pristanic acid (C-19) ?
α-Oxidation of fatty acids
• Fatty acids with a methyl group at the β-carbon
undergo α-oxidation as methyl blocks β-oxidation

• Phytanic acid presents in milk, animal fats &


chlorophyll

• Site: peroxisomes

• Hydroxylation at the α-carbon by phytanoyl α-


hydroxylase removes C-1

• The product, pristanic acid (C-19), is activated to its


CoA derivative & undergoes β-oxidation
Phytanic acid
24
α-Oxidation of
phytanic acid

Refsum’s disease

25
ω-oxidation
• An alternative minor pathway for fatty acid
degradation

• In ER of liver & kidney

• Preferred substrates: C10 & C12 fatty acids

• Introduces “OH” onto the ω-carbon from O2

• “e” doner NADPH

• Enzymes: cytochrome P450 (mixed function oxidases)

26
27
Regulation of fatty acid oxidation

• Hormones control the supply of fatty


acids in the blood

• CAT I is inhibited by malonyl CoA


(ACC)

• The rate of ATP utilization controls the


rate of the ETC

• Regulates the oxidative enzymes of -


oxidation & the TCA cycle

28
Coordinated regulation of fatty
acid synthesis and breakdown
29
Ketone bodies

30
Ketogenesis
• During starvation & DM, the acetyl- CoA takes the alternate
fate of formation of ketone-bodies

• Excess acetyl CoA derived from fatty acid, pyruvate or


ketogenic amino acids oxidation have been converted to
ketone bodies in liver

• Ketone bodies are water soluble and an alternative fuel for


cells

Acetoacetate β-3-hydroxybutyrate Acetone 31


Cont.…
1. Two molecules of acetyl-CoA are condensed to acetoacetyl-CoA by
thiolase (acetyl-CoA acetyltransferase)

[Link] of the acetoacetyl-CoA with a third acetyl-CoA by HMG-


CoA synthase forms 𝛃-hydroxy-𝛃-methylglutaryl-CoA (HMG-CoA)

[Link]-CoA is degraded to acetoacetate and acetyl-CoA by HMG-CoA


lyase

• HMG-CoA is also a precursor in cholesterol biosynthesis (Cytosol)

• However, HMG-CoA lyase is present only in liver mitochondria and


therefore does not interfere with cholesterol synthesis
32
33
Regulation of ketogenesis

• Fasting ⟹glucagon ⟹lipolysis ⟹ ketogenesis

• Acetyl Co A ⟹⇊pyruvate dehydrogenase ,⇈pyruvate


carboxylase

• OAA ⟹ gluconeogenesis (not TCA cycle)


⟹ acetyl CoA ⟹
• ⇊NAD+/NADH ⟹ OAA ⟹malate ketogenesis

36
Ketolysis
• The ketone bodies are formed in the liver; but they are
utilized by extrahepatic tissues

• Heart muscle and renal cortex prefer the ketone bodies


than glucose

• Skeletal muscle and brain utilize the ketone bodies as


alternate sources of energy, if glucose is not available

• Acetoacetate is activated to acetoacetyl CoA by


Thiophorase (3-ketoacyl-CoA transferase) enzyme

37
38
39
Ketone bodies are overproduced in DM
and during starvation
• Starvation ⇒ Gluconeogenesis depletes citric acid cycle intermediates

• Untreated DM ⇒ low insulin level leads to inefficient glucose uptake from


the blood
• These conditions leads to low malonyl-CoA, and in turn CPTI free of
inhibition I is relieved

• Fatty acids enter mitochondria degraded to acetyl CoA, and accumulated

• This favors the formation of ketone bodies beyond the capacity of


extrahepatic tissues to oxidize them

• The increased blood levels of acetoacetate and β-hydroxybutyrate lower the


blood PH……….. Acidosis………….. ketosis
40
41
5. Cholesterol Synthesis, transport, & excretion

42
Cholesterol Synthesis
• Cholesterol is a sterol synthesized by virtually all tissues in
humans, but largest contribution are made by:
─ Liver
─ Intestine

• Precursor for:

─ Corticosteroids
─ Bile acids
─ Sex hormones
─ Vitamin D
43
Cont.…
Source of cholesterol
• Diet: 300mg/day

• Synthesis within most cells: 700mg/day

• Precursor: acetyl CoA for all 27 carbon

: ATP and NADPH

• Site: cytosol, endoplasmic reticulum

44
Summary of cholesterol biosynthesis

45
Cont.…
Steps in cholesterol biosynthesis

1. Initial condensation reactions produce HMG CoA, which is


reduced to mevalonate→ Committed Step

[Link] units are formed from mevalonate though loss of


CO2

[Link] isoprenoid units are condensed to form Squalene

[Link] is cyclizes to give rise to parent steroid lanosterol


which is converted to cholesterol by a series of changes
46
I : Acetyl CoA to mevalonate

Committed Step

Statin …………..

47
II Mevalonate to DPP

48
(DPP)
III Formation of squalene

NADP PPi

NADPH + H

49
IV Formation of cholesterol

50
IV Squalene to cholesterol

Squalene
epoxide

51
52
Metabolic fates of cholesterol

53
Regulation of cholesterol biosynthesis
1. Hepatic synthesis is inhibited by dietary cholesterol

[Link] CoA reductase is inhabited by cholesterol

[Link] & thyroid hormone increase HMG CoA reductase


activity where as glucagon & glucocorticoids decrease

[Link] CoA reductase synthesis is also controlled at


transcription level

54
Mevalonate
Cholesterol
Bile acid ⊖

Regulation of cholesterol formation 55


6. Lipid transport and storage

56
Cholesterol & other lipids are carried on plasma lipoproteins

• Lipids (C,CE,TAG,PL) are transported in the plasma as plasma


lipoproteins, complexes of specific carrier proteins,
apolipoproteins

• Spherical complexes with hydrophobic lipids in the core and


hydrophilic amino acid side chains at the surface

• However, free fatty acids are carried on albumin

57
58
Cont.…
• Each class of lipoprotein has a specific function, determined by its
point of synthesis, lipid composition & apolipoprotein content

59
Cont.…
• Ten distinct apolipoproteins are found in the lipoproteins of human plasma

60
Cont.…

Lipoproteins Apoprotein
• Chylomicrons A,B-48, C,E
• VLDL B-100,C,E
• LDL B-100
• IDL B-100,E
• HDL A,C,E

61
Cont.…
• Apolipoproteins carry out several roles

❖ Structure of the lipoprotein (apo B)

❖ Cofactors (apo C-II for lipoprotein lipase)

❖ Ligands for lipoprotein receptors ( apo B-100 &


apo E for the LDL receptor)

62
Chylomicron
• Nanscent chylomicron are synthesized from dietary fats in the ER
of enterocytes, small intestine

• TAGs, PL, Cholesteryl easter, apoB-48 and apo-E enter lymphatic


system,& reach circulation

• apo-C-II and E from HDL make matured chylomicron in


circulation

• ApoC-II activates lipoprotein lipase in capillaries (adipose, heart,


skeletal muscle, & lactating mammary tissues) to release of FFA

63
Cont…
• The remnants of chylomicrons (depleted of most of TAG but
containing cholesterol, apoE, and apoB-48) move through the
bloodstream to the liver

• Receptors in the liver bind to the apoE in the chylomicron


remnants and mediate their uptake by endocytosis

• In the liver, the remnants release their cholesterol and are


degraded in lysosomes

64
Lipoproteins and lipid transport

Chylomicron receptor

65
VLDL
• Excess fatty acids & carbohydrate from diet are converted into
TAGs in the liver and exported as VLDL to muscle & adipose tissue

• VLDL contains apo B-100, apoC-I, apoC-II, apoC-III, and apoE

• ApoC-II activates lipoprotein lipase, which catalyzes the release of


free fatty acids from TAGs in VLDL

• Adipocytes take up these fatty acids, reconvert them to TAGs

66
LDL
• The loss of TAGs converts some VLDL to VLDL remnants (intermediate-
density lipoprotein, IDL) in the blood

• Further removal of triacylglycerol from IDL produce LDL

• LDL contains cholesterol, cholesteryl esters & apoB-100 which carries


cholesterol to extrahepatic tissues (muscle, adrenal glands & adipose)

• Plasma membrane LDL receptors recognize apoB-100 and mediate


the uptake of cholesterol and cholesteryl esters

• LDL also delivers cholesterol to macrophages which convert them into


foam cells 67
Indigenous pathway

68
Cont.…
• LDL not taken up by peripheral tissues and cells returns to the liver and
is taken up via LDL receptors in the hepatocyte plasma membrane

• Cholesterol that enters hepatocytes by this path may be incorporated


into membranes, converted to bile acids, or reesterified

• VLDL formation & LDL return to the liver is the endogenous pathway
of cholesterol metabolism and transport

• Accumulation of excess intracellular cholesterol is prevented by


reducing the rate of cholesterol synthesis

69
70
Cont.…
• LDL receptors are synthesized in the Golgi complex and transported to the
plasma membrane, bind apoB-100

• The binding of LDL to an LDL receptor initiates endocytosis, which conveys the
LDL and its receptor into the cell within an endosome

• The receptor-containing portions of the endosome membrane bud off and are
returned to the cell surface, to function again in LDL uptake

• The endosome fuses with a lysosome, hydrolyzes the cholesteryl esters, releasing
cholesterol & FA into the cytosol

• The apoB-100 protein is also degraded to amino acids

• Conversion of VLDL to LDL exposes receptor-binding domain of apoB-100, but


not in VLDL 71
Cholesteryl esters enter cells by receptor-mediated endocytosis
mutation

familial
hypercholesterolemia
(FH)

72
Cont.…
• LDLs are rich in cholesterol and cholesterol esters
❖60% →→ liver to be endocytosed
❖40%→→ extrahepatic tissues (adrenocortex, gonads)

Excess LDL uptake by macrophages

Induce an inflammatory response

Initiate the complex cascade of


atherosclerosis
73
HDL carries out reverse cholesterol transport
• High density lipoprotein (HLDL) originates in the liver and small
intestine

• Contains apoA-I , apoC, apoE, lecithin-cholesterol acyl transferase


(LCAT), little cholesterol & no cholesteryl esters

• LCAT catalyzes the formation of cholesteryl esters from lecithin &


cholesterol

• A major function of HDL is to act as a source for the apoC & apoE for
metabolism of chylomicrons and VLDL

• Nascent HDL consists of discoid phospholipid bilayers containing apo A


and free cholesterol
74
Cont…
• The surface PL & free cholesterol are converted
into cholesteryl esters & lysolecithin

• Cholesteryl esters moves into interior of HDL


disk (Matured HDL)

• HDL becomes spherical due to accumulation of


cholesteryl esters

• Nascent HDL can also pick up cholesterol from


cholesterol-rich extrahepatic cells

❖ Macrophages and foam cells formed from


macrophages
• Mature HDL returns to the liver, unloaded
cholesterol via the scavenger receptor (SR-BI) 75
Cont….
• Excess unesterified cholesterol removed from HDL by:
❖ Scavenger receptor (SR-B1)

oBinds HDL via apo A-I & cholesteryl ester is selectively delivered to
the cells (liver)

oMediates the acceptance of cholesterol effluxes from the cells by


HDL (tissue)

oFree apo A-I is released & destroyed


❖ATP-binding cassette transporters A1 (ABCA1) & G1 (ABCG1)

o ABCG1 mediates the transport of cholesterol from cells to HDL via


coupling the hydrolysis of ATP
76
Metabolism of high-density lipoprotein (HDL) in reverse cholesterol transport 77
Cont….
• The HDL circuit is reverse cholesterol transport

• Depleted HDL then dissociates to recirculate in the bloodstream


and extract more lipids

• Cholesteryl esters from HDL is transferred to VLDL,IDL & HDL


by cholesteryl ester transfer protein (CETP) in exchange for TAG

78
Reverse cholesterol transport
• ApoA-I and HDLs pick up excess cholesterol from peripheral cells, with the participation of
ABCA1 and ABCG1 transporters, and return it to the liver

• Genetically defective ABCA1, the failure of reverse cholesterol transport leads to severe and
79
early cardiovascular diseases: Tangier disease and familial HDL deficiency disease

You might also like